JPMorgan Raises UnitedHealth (UNH) Price Target to $466
JPMorgan raised its price target on UnitedHealth Group (UNH) to $466 from $420, keeping an Overweight rating. The move follows updated healthcare service models. Mizuho also raised its target on the same day.
Key Numbers
JPMorgan raised its price target on UnitedHealth Group Incorporated (NYSE:UNH) to $466 from $420 and maintained an Overweight rating on the shares, according to a report dated June 8, 2026.
Rating Change
- Previous Price Target: $420
- New Price Target: $466
- Rating: Overweight
Analyst Rationale
JPMorgan updated its healthcare service models, leading to higher revenue and earnings estimates. Analysts believe UnitedHealth is well-positioned to benefit from aging demographics and growing demand for long-term healthcare services.
Context
On the same day, Mizuho also raised its price target on the stock, reflecting a broadly positive analyst outlook. UnitedHealth is one of the largest health insurers and healthcare services companies in the U.S. and is considered a top pick in the healthcare sector.
What This Means
A price target hike from a major investment bank like JPMorgan signals confidence in UnitedHealth's growth prospects. However, investors should note that ratings do not guarantee future performance, and the stock may be affected by broader market conditions and regulatory developments in healthcare.
Frequently Asked Questions
Found this useful? Share it